Objectives: Scarring caused by trauma, postcancer treatment, or inflammation in the vocal folds is associated with stiffness of the lamina propria and results in severe voice problems. Currently there is no effective treatment. Human embryonic stem cells (hESC) have been recognized as providing a potential resource for cell transplantations, but in the undifferentiated state, they are generally not considered for therapeutic use due to risk of inadvertent development. This study assesses the functional potential of hESC to prevent or diminish scarring and improve viscoelasticity following grafting into scarred rabbit vocal folds.
INTRODUCTION
Vocal fold scarring is the most common cause of severe voice disturbances. 1, 2 The causes may be trauma, postcancer treatment, inflammation, or congenital. This leads to decreased viscoelasticity of the vocal fold lamina propria, which reduces the vibration potential of the vocal folds. In vocal fold scarring, the voice is often severely dysphonic or aphonic and phonation is strained. Currently there are no effective treatment methods. Recent research focusing on injection augmentation of molecules in the extracellular matrix (e.g., collagen, hyaluronic acid, etc.) has led to several important findings. Hyaluronan is thought to be important for the vocal fold function and injection may improve viscoelasticity in scarring. [3] [4] [5] [6] Kanemaru et al. injected autologous mesenchymal stem cells (MSC) after a scarring procedure in canine and rat vocal folds. 7 Injected folds showed normalized macroscopic appearance after 2 months in contrast to the defective healing (e.g., atrophy, granuloma formation) found in untreated control folds. A later study showed that the stem cells survived and differentiated in the implanted rat vocal folds. 8 In a recent experiment, we injected human MSC into scarred rabbit vocal folds and found a low degree of survival of the transplanted MSC. However, healing was improved as compared to non-treated scarred vocal folds with less collagen type 1 content in the lamina propria and improved viscoelasticity of the vocal fold tissue. 9 Since the first description of successful in vitro culture of hESC, such cells have been recognized as providing a potential resource for cell transplantations. 10 Here, we examined the survival and development of undifferentiated hESC injected into scarred rabbit vocal folds with the intention to assess their functional potential to prevent or diminish scarring. Others have reported on similar approaches to verify the functional capacity of hESC and their cell derivatives for functional regeneration of specific tissues in vivo. Muotri et al. 11 performed xenografts of hESC into mouse embryonic brain and found support for hESC being responsive to environmental signals and to acquire both morphologic and functional differentiation with regional specificity. Goldstein et al. 12 found that hESC transplanted into or in place of epithelial-stage somites of chick embryos of 1.5 to 2 days of development integrated well, and that this environment may modulate hESC differentiation. Both these studies showed a regional impact on hESC differentiation after xenografting to an embryonic environment, mouse 11 and chick, 12 respectively. Our study addresses and extends this notion to adult tissue in the rabbit and demonstrates a regionspecific hESC differentiation into muscle, cartilage, and epithelium leading to a measurable functional restoration of scarred vocal folds.
MATERIALS AND METHODS

Ethical Permission
This study was performed with the permission of the Local Ethics Committee at Karolinska Institutet (114/00) and by the Regional Committee of South Stockholm for Animal Experimentation (S-172-03 and S-224-04).
Cells
The hESC line HS181(46;XX), 13 derived by the hESCnetwork at Karolinska Institute was maintained as previously described on mitotically inactivated (35 Gy irradiation) human foreskin fibroblasts. 14 HS181 cells corresponding to passage 32 from two separate thawings were used in this study.
Xenograft Model
Two similar experiments using female New Zealand white (NZW) rabbits were performed (the body weight of rabbits in experiment one was 4.6 to 4.9 kg, and in experiment two was 2.9 to 3.2 kg).
Experiment one included 11 rabbits. Of the total 22 vocal folds, 5 were not operated ("untreated control"), 6 were operated with a scarring procedure only ("scarred untreated control"), and 11 vocal folds were scarred and injected with hESC ("scarred hESC injected"). Experiment two included 10 rabbits, but 1 died during the anesthesia before the scarring procedure. Thus, of the 18 vocal folds in experiment two, 3 were used as untreated controls, 4 were scarred untreated controls, and 11 were scarred hESC injected.
Vocal Fold Scarring
After premedication with glycopyrrolate (0.15 mg/kg subcutaneously) and Hypnorm (fentanyl 0.3/mg/mL mixed with fluanizonum 10 mg/mL, 0.3 mL/kg IM), all animals were anesthetized with diazepam 2 mg/kg IV. The laryngeal structures and the mobility at the cricoarytenoid joints were found normal by examination using a modified 4.0 mm pediatric laryngoscope (model 8576E, Karl Storz Endoscope, Tuttlingen, Germany) and a Storz-Hopkins 0°2.7 mm rigid endoscope (model 7218A), i.e., no scarring or vocal fold immobility. A digital video recording on computer was made of the vocal folds before and after the scarring procedure (Richard Wolf video camera No 5512, and Canopus ADVC100 digital video converter, Reading, U.K.). The scarring procedure was performed with a microcup forceps and microscissors, resulting in a wound dimension approximately corresponding to 2 mm, the size of the forceps (MicroFrance Medtronic, Dü sseldorf, Germany). The localized excision of the mucosa and superficial thyroarytenoid muscle was made under video monitoring (Fig. 1A) .
hESC Injections Into Scarred Vocal Folds
Directly after the scarring procedure, injections were made under video monitoring into the lamina propria and/or to the superficial part of the thyroarytenoid muscle of the vocal fold using a Medtronic Xomed laryngeal injector. Three to four undifferentiated hESC colonies (approximately 10 4 cells) were dissected directly from the culture plates by a 27-gauge needle, carefully avoiding the surrounding feeder cells, and then injected using the same syringe.
In total (both experiments), 22 of the 32 scarred vocal folds were injected with hESC (10 4 cells in 0.1 mL saline). Ten vocal folds were injected only with 0.1 mL saline. Eight non-scarred vocal folds were used as controls. No animal suffered from breathing problems or bleeding after the injections. All hESC-injected animals were treated with a low dose of immunosuppressant (tacrolismus 0.05 mg/kg bw subcutaneously) every second day during 1 month. 9 All animals maintained body weight, and no signs of side effects from the treatments were noted during the observation period.
Dissection of Vocal Folds
In both experiments, the animals were sacrificed 4 weeks after the injections using an IV overdose of sodium pentobarbital. The larynges were dissected out and each larynx was divided in the posterior midline. Twenty-eight of the hemilarynges (all 22 from experiment one and 6 from experiment two) were stored in 4% formaldehyde for later preparation and histologic analysis (6 untreated controls, 6 scarred controls, and 16 scarred hESC injected). Twelve of the 18 hemilarynges from experiment two were immediately fresh-frozen at -20°C prior to viscoelastic analysis (2 untreated controls, 4 scarred controls, and 6 scarred hESC injected).
Histologic Measurements
After fixation in 4% formaldehyde, the vocal folds removed from the hemilarynges were further processed, dehydrated, and finally embedded in paraffin wax and cut into 5-m thick sections. 9 Sectioning was made throughout the whole thickness of the vocal fold. The sections corresponding to the vocal fold level where the scarring was performed were then stained using hematoxylin-eosin for histologic analysis. Digitization of the microscopic images was followed by image analysis at 20ϫ or 40ϫ magnification using a Nikon digital camera, DXM 1200, attached to a Nikon Eclipse, E600 microscope (Tokyo, Japan). Measurements of the mean lamina propria thickness were made with the software Image Pro Plus (version 3.0, Media Cybernetics, Bethesda, MD).
Viscoelastic Measurements
Viscoelastic measurements were performed using parallelplate rheometry. The linear viscoelastic shear properties of vocal fold tissue have been previously studied by several researchers. 15, 16 An AR 2000 Rheometer (TA Instrument, New Castle, DE) with a stationary lower plate (8-mm diameter) separated by about 0.5 mm from a rotating upper plate was used. This parallelplate rheometer produces sinusoidal shear, small amplitude oscillations at increasing frequency (0.01-15 Hz). Tissue samples from freshly frozen vocal folds were thawed, dissected, and analyzed at 37°C in the parallel-plate rheometer. The control samples were used to calibrate the equipment (data not shown). All rheometric measurements were performed in the linear region with a constant strain level transferred from the sample to the upper plate where it was measured with a linear variable displacement transducer. The response and reproducibility of several frequency sweeps were stable up to about 3 Hz. The dynamic viscosity (͉n*͉, Pa.s) and storage (elastic) modulus (GЈ, Pa) were derived as a function of frequency. Dynamic viscosity is a measure of a material's resistance to shear flow; the elastic (storage) modulus (GЈ) represents a measure of a material's stiffness in shear. In the results presented, the absolute levels of Ј and GЈ may not be fully accurate since the gap between the plates could not be completely filled with tissue. However, the same dissection procedure and amount of tissue was used for all samples, and this allows comparison between the different treatment groups.
Paraffin Removal and RNA Extraction for RT-PCR
Paraffin-embedded tissue was deparaffinized for RNA extraction and expression analysis with RT-PCR. Sections of paraffin-embedded tissue were treated with octane/methanol, precipitated by centrifugation, and homogenized using Trizol (Invitrogen Corporation, Foster City, CA) in accordance with the manufacturer's protocol.
RT-PCR
Species-specific expression analysis was performed for collagen type 1, and also for Nanog, a transcription factor 
RNA was reversed transcribed using a Superscript III First Strand Synthesis System (Invitrogen Corporation) according to the manufacturer's protocol, and PCR was performed with Platinum Taq-polymerase (Invitrogen Corporation). Human specific primers (Cybergene) and conditions used were the following: Collagen type 1: F: 5Ј-TTCCCCCAGCCACAAAGAGTC-3Ј, R:5Ј-CGTCATCGCACAACACCT-3Ј, 50°C, 35 cycles, 261 bp. Nanog: F:5Ј-CGGCTTCCTCCTCTTCCTCTATAC-3Ј, R:5Ј-ATCGATTTCA-CTCATCTTCACACGTC-3Ј, 60°C, 30 cycles, 960 bp.
Immunohistochemistry
FISH Analysis for Persistence of Transplanted hESC
Detection of human cells with fluorescence in situ hybridization (FISH) analysis was performed as previously described. 9 Briefly, slides were deparaffinized in xylene and rehydrated in a series of alcohol, followed by pretreatment with pepsin. Genomic DNA and probe were denatured simultaneously by heating at 74°C for 8 minutes. Hybridization was performed overnight at 38°C with a human-specific fluorescent probe (SpectrumRed human genomic DNA, Vysis Inc., Downers Grove, IL), which tested negative in non-hESC injected rabbit vocal folds, ensuring that the probe is not cross-reacting with cells of rabbit origin. Finally, the slides were mounted with Vectashield containing DAPI (Vector Laboratories Inc., Burlingame, CA). Sections from 3 to 5 levels of the vocal fold thickness for each sample were used for FISH analysis to determine the engraftment.
Collagen Staining
This was performed on sections immediately surrounding hESC positive sections (as detected by FISH).
Staining was performed as previously described. 9 Briefly, slides were deparaffinized in xylene, rehydrated in a series of alcohol, and blocked in phosphate buffered solution (PBS) containing 3% bovine serum albumin (BSA). Slides were incubated with a primary antibody diluted 1:200 (antibody 6308, Abcam, Cambridge, UK), followed by incubation with a Cy3-conjugated secondary antibody diluted 1:400 (antibody A21127, Jackson ImmunoResearch Labs Inc., West Grove, PA). Sections were rehydrated in ethanol and xylene and mounted with Vectashield containing DAPI (Vector Laboratories, Inc.).
The relative content of collagen type 1 in the vocal folds was measured from the digitized stains after a color filtering and normalization process using Adobe Photoshop (version 8.0, Adobe, San Jose, CA) and custom-made software (Hans Larsson, Karolinska Institutet, Department of Logopaedics and Phoniatrics, Stockholm, Sweden). One image (corresponding to the level of FISH analysis) from each of the 13 animals was evaluated (2 untreated controls, 4 scarred controls, and 7 scarred hESC injected).
Statistics
Non-parametric comparisons (Statview, version 5.0, SAS Institute Inc., Cary, NC) between the groups were made. For measurements of the dynamic viscosity and the elastic modules, Wilcoxon's paired comparison of mean values was used for all frequencies. Due to the exploratory nature of the study, significance levels with P Ͻ .05 are reported.
RESULTS
Histologic Analysis
Measurements of the thickness of the lamina propria (lp) were performed on 2 untreated controls (Fig. 1B), 4 scarred untreated (Fig. 1C, D) , and 11 scarred hESCinjected vocal folds (Fig. 1E) . The scarred untreated vocal folds had the thickest lp with a of mean 210 m (SD 178); scarred hESC-injected folds had a mean of 130 m (SD 79); and the untreated control samples had a mean of 120 m (SD 97) (nonsignificant differences).
The samples from the scarred untreated group all showed polyps or thick collagen bundles in the lp (Fig. 1C,  D) . The scarred hESC-injected group had polyps in only 2 of 11 samples, and thus showed less deviation regarding lamina propria structure and thickness as compared to the untreated controls group (0 of 2 with polyps; Fig. 1B ).
Collagen Type 1 Content
Seven scarred hESC-injected vocal folds had relative collagen contents of between 4.2 and 25.2%, respectively, of the total slide area, while the four scarred untreated samples showed collagen contents between 5.0 and 8.5%. The untreated control vocal fold samples had collagen type 1 content of 1.7% and 4.6%, respectively. With one exception (one animal in the scarred hESC-injected group), no significant difference in collagen type 1 levels was detected when the different groups were compared. Notably, this sample (with the highest relative collagen content; 26%) was one of the very rare cases (2 of 11) with polyp formation in this group (see Histologic Analysis).
The collagen type 1 in the hESC-injected group was not of human origin as detected by RT-PCR using primers specific for human collagen (data not shown).
Persistence, Differentiation, and Engraftment of hESC After Transplantation
The Histologic analysis of hESC-injected vocal folds revealed regional specific differentiation of human cells into types of tissues normally seen in vocal folds, i.e., cartilage, muscle, and epithelium (shown in Figs. 1F-K) . All the hESC-injected areas (in 11 of 11 scarred hESC-injected vocal folds) showed a similar formation of human cartilage intermixed with rabbit cartilage. In addition, in 3 of these 11 scarred hESC-injected vocal folds, areas compatible with the formation of human cartilage were detected in immediate proximity to the native rabbit cartilage, but clearly separated from the existing cartilage. Human muscle was detected in 5 of 11, and epithelium of human origin was found in 3 of 11 scarred hESC-injected vocal folds. The hESC-derived areas were generally limited to the immediate injection location. However, in 1 of the 11 scarred hESC-injected vocal folds, the posterior part of the lamina propria consisted of a larger area of human origin, not only differentiated into cartilage, muscle, and epithelium, but also into glands with normal histology ( Fig. 1M and Fig. 2 ). This vocal fold also contained a small area with subepithelial lymphocytes of rabbit origin, indicating a local cellular immune reaction despite the immunosuppressive treatment.
Expression of Nanog
Results from the RT-PCR revealed expression of human Nanog in all tested vocal folds injected with hESC, indicating the presence of pluripotent cells after 1 month.
Viscoelastic Analyses
This analysis is illustrated in Figure 3 . The group of scarred hESC-injected larynges showed significantly lower dynamic viscosity (Ј, Pas) than did the scarred untreated samples (P ϭ .03). Scarred hESC-injected vocal folds had a significantly lower elastic modulus (stiffness) than the scarred untreated folds did (P ϭ .03).
DISCUSSION
Three types of tissues were regenerated at the site of hESC injection. Following what appears as a regional specific in vivo differentiation of the injected hESC, areas compatible with cartilage, human muscle, and epithelium development were observed as integrated parts of, or in close contact to, the appropriate native rabbit tissues of the vocal folds. Except for this immediate regeneration of tissue originating from the injected human cells, it cannot be excluded that the hESC or its derivatives may also have a paracrine effect on the surrounding tissue. From the FISH analysis for human cells at different levels throughout vocal fold thickness, it was clear that human cells were detected in close proximity to the injection site. Larger areas of human tissue, expanding outside the site of injection and indicating what could be perceived as more unrestricted growth, was detected in only 1 of the total 22 hESC-injected vocal folds. In this case, most of the posterior part of the lamina propria was found to consist besides human cartilage, muscle, and epithelium, also of tissue compatible with human glands, however, without any apparent signs of anaplasia or resemblance of teratoma formation. Somewhat surprising, and given reservations of performing and evaluating a complete histopathologic analysis, all analyzed samples of the human tissues formed were judged as histopathologically normal. Areas with cells of malignant phenotype could not be detected within the observation period of 1 month. Long-term studies following the hESC transplantation, where cells have the opportunity to develop into maturer or even adult tissues, are needed before we can understand the risks when using these cells for clinical purposes. A long-term study is ongoing and is hoped to reveal a possible occurrence of such later effects.
Hematoxylin-eosin staining indicated improved wound healing, in that a lower occurrence of polyp formation was detected in the hESC-treated vocal folds. Furthermore, functional studies measuring the viscosity and elastic modulus of the vocal folds revealed that the scarred and hESC-injected vocal folds also showed a significantly reduced viscosity and less elastic modulus compared to the sham-treated scarred vocal folds.
Scarring and stiffness of vocal folds has previously been attributed to increased collagen content of the lamina propria. 17 Thus, improved wound healing is possibly accompanied by reduced levels of collagen. In a study using human adult MSC in the regeneration of scarred rabbit vocal folds, we found that MSC injection significantly reduced the content of collagen type 1, possibly contributing to a parallel observed functional improvement in the MSC-injected vocal folds. 9 In contrast, our present study using hESC indicated no significant differences in collagen type 1 levels when comparing the stem cell-injected vocal folds and the untreated scarred folds. The exception was one hESC-injected fold with high collagen type 1 content and polyp formation, as seen with hematoxylin-eosin (H&E) staining. This indicates that the functional improvement observed was not due to levels of collagen type 1, but rather depended on other factors. Furthermore, it cannot be excluded that the collagen type 1 found in the hESC-treated folds influences the differentiation of the transplanted hESC with a positive functional result. Recently, Leor et al. showed that fetal human umbilical cord blood-derived stem cells could prevent scar thinning in athymic nude rats following induced myocardial infarction. 18 A strong correlation between scarring and collagen levels suggests that early types of human stem cells might have a collagen-increasing effect in wound-healing. Sato et al. showed that enhanced synthesis of collagen in in vitro cultures of murine embryonic stem cells stimulated differentiation into tissues of mesodermal origin, including cartilage and muscle. 19 This leads to the suggestion that collagen production in scar formation might stimulate the transplanted cells to differentiate into the mesodermal lineage, and with possible species differences in mind, this could be an explanation for the rapid differentiation and development of cartilage and muscle in our study. Interestingly, formation of cartilage per se is not likely to contribute to the improved viscoelasticity, rather the opposite, which is why the reason for this effect must be further explored. In addition to collagen type 1, other factors and molecules may be important to vocal fold function in the treatment of scarring, such as the content of elastin, fibromodulin, fibronectin, and procollagen/collagen type 3. The relative proportions of these molecules in the extracellular matrix are likely to be important, and the functional improvement is possibly due to changed connections caused by changes in the matrix protein levels, rather than the reformation of tissue.
The data presented do not exclude a possibility that the immunosupression per se was responsible for the effects observed. However, in the same model, we have in other studies not seen any positive effects on wound healing by giving only immunosuppression to the vocal fold scarred animals (Svensson et al., 2007, manuscript in preparation). In this context it is interesting to note that H&E-stainings revealed signs of immune reactions with host lymphocyte infiltration, despite immunosupression. Thus, the immunosuppressant regimen used did not entirely block the immune effects.
From a clinical point of view, there is still much to learn before hESC derivatives can be used in cell therapy and transplantation. Our previous results using MSC in the same model reveals, however, that this might be suitable for clinical purposes . Even though the MSC do not show the same ability to tissue regeneration, they have a significant functional effect without apparent risks for anaplasia.
CONCLUSION
The data presented indicate that following in vivo injection into adult rabbit vocal folds, hESC not only have the ability for survival and engraftment (5.1%), but also show correlation to local differentiation signals leading to regional specific formation of cartilage, muscle, and epithelium. The enhanced tissue repair was paralleled with a functional regeneration, measured as improved viscoelastic properties, of the vocal folds after scarring. Within the short time frame of the study, no histologic anaplasia was observed. Although the findings are encouraging and verify the potential of functional replacement therapy for scarred vocal folds, the risk for adverse formation of unwanted tissue, indicated by findings in 1 of 22 vocal folds, needs to be further investigated. Ongoing studies will also reveal the longterm persistence of cells and function.
